The trial failure is a blow to hopes that Alzheimer's could open a major new market for GLP-1 medicines such as semaglutide, as Novo faces rising competition to its blockbuster drugs in its core treatment areas of obesity and diabetes
North Carolina State Health Plan Similarly, North Carolinas State Health Plan took action in January 2024 that took effect in April of last year, formally removing coverage for GLP-1 and GIPGLP-1 agonists when used for weightloss in obesity
The medication can cause increased heart rate and palpitations
Noom pairs medication with coaching and habit-building tools, while Medvi focuses more on telehealth prescribing and fulfillment
Addressing this unmet need head-on is critical, and while there are pharmaceutical treatments for the excessive sleepiness associated with OSA, tirzepatide has the potential to be the first pharmaceutical treatment for the underlying disease. Currently, the gold standard of treatment for OSA is CPAP therapy